AptarGroup’s CHRO Makes a Significant Stock Sale

New insider activity at AptarGroup ( (ATR) ) has taken place on May 9, 2025.

Shiela Vinczeller, the Chief Human Resources Officer at AptarGroup, recently executed a sale of 995 shares of the company’s stock, amounting to a total transaction value of $151,657.

Recent Updates on ATR stock

In the past 24 hours, AptarGroup’s stock has seen notable developments following its Q1 earnings report. Wells Fargo raised its price target for AptarGroup, citing a high-quality earnings beat driven by growth and margin improvement in its largest profit segment despite macroeconomic challenges. The company’s proprietary drug delivery systems showed robust growth, contributing to a positive outlook. However, Raymond James lowered its price target due to mixed segment performance and economic pressures. AptarGroup’s Q1 results revealed a 3% sales decline, but the pharma segment grew, and adjusted EBITDA increased by 3%. The company remains optimistic about future growth, supported by strategic innovations and a strong market position in resilient sectors.

Spark’s Take on ATR Stock

According to Spark, TipRanks’ AI Analyst, ATR is a Outperform.

AptarGroup presents a solid financial foundation characterized by robust profitability and efficient cash flow management. The stock’s technical indicators suggest short-term strength, while the recent earnings call highlights growth in key segments despite some market challenges. Valuation remains a concern, as the P/E ratio suggests potential overvaluation. Overall, the company’s strong financial health and positive earnings outlook support a favorable stock score, tempered by valuation considerations.

To see Spark’s full report on ATR stock, click here.

More about AptarGroup

YTD Price Performance: -3.36%

Average Trading Volume: 380,847

Technical Sentiment Signal: Buy

Current Market Cap: $9.97B